Matthew Harrison Analyst Performance

Matthew Harrison is a stock analyst at Susquehanna, covering 49 publicly traded companies across a range of sectors. Over the past year, Matthew Harrison has issued 37 stock ratings, including buy and hold recommendations. While full access to Matthew Harrison's proprietary MarketBeat Analyst Rating is reserved for MarketBeat All Access subscribers, the rating is updated daily to reflect the most recent analyst activity. This profile highlights Matthew Harrison's coverage history, rating activity, and performance tendencies — helping individual investors make more informed trading decisions.

Analyst Ratings, Coverage, and Performance Statistics

Analyst Rating

Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating MarketBeat

Average Return

00.00% 12-Month ROI

Success Rate

00.00% Profitable Ratings

Total Ratings

218 Last 11 Years

Buy Recommendations

47.39% 100 Buy Ratings

Companies Covered

49 Unique Companies

Ratings Distribution

Rating	Percentage	Count
Strong Buy	0.0%	0 ratings
Buy	47.4%	100 ratings
Hold	46.4%	98 ratings
Sell	6.2%	13 ratings

Out of 211 total stock ratings issued by Matthew Harrison at Susquehanna, the majority (47.4%) have been Buy recommendations, followed by 46.4% Hold and 6.2% Sell.

Best & Worst Calls

• Best Call

  0000.0%

  MRNA

  Aug 2019

  Subscribe to MarketBeat All Access to get analyst recommendation ROI.
• Worst Call

  000.0%

  LYEL

  Jan 2022

  Subscribe to MarketBeat All Access to get analyst recommendation ROI.

Exchange Coverage

Exchange	Percentage	Count
NASDAQ	81.6% of companies on NASDAQ	40 companies
NYSE	18.4% of companies on NYSE	9 companies

Matthew Harrison, an analyst at Susquehanna, currently covers 49 companies listed on NASDAQ and NYSE, with the majority traded on NASDAQ.

Coverage Focus

Sector Icon	Sector	Percentage
	Medical 47 companies	95.9%
	Transportation 1 company	2.0%
	Consumer Discretionary 1 company	2.0%

Matthew Harrison of Susquehanna specializes in stock coverage within the Medical sector, with additional focus on Transportation and Consumer Discretionary companies.

Coverage Industries

Industry	Percentage
MED - BIOMED/GENE 28 companies	57.1%
PHARMACEUTICAL PREPARATIONS 7 companies	14.3%
LARGE CAP PHARMA 5 companies	10.2%
BIOLOGICAL PRODUCTS, EXCEPT DIAGNOSTIC 2 companies	4.1%
MED - DRUGS 2 companies	4.1%
BIOTECHNOLOGY 2 companies	4.1%
TRANS - EQP&LSNG 1 company	2.0%
CABLE TV 1 company	2.0%
MED PRODUCTS 1 company	2.0%

Matthew Harrison's Ratings History at Susquehanna

Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 4 Years 5 Years All Time Time Frame

Start Date

End Date

All Ratings Strong Buy Buy Hold Sell Rating

Recommendation ROI is the percentage between the price on the Report Date to the price 12 months after the report date.
Available with a MarketBeat All Access Subscription

12-Month ROIUpgrade to All Access to use the All ROI Filter

Export to Excel

Company	Report Date	Action	Report Date Price	12-Month Price Target	Rating	12-Month Price & ROI	Details
DNLI Denali Therapeutics	8/18/2025	Lower Price Target	$14.81	$30.00	Overweight	$0.00 00.00% ROI
INSM Insmed	8/13/2025	Reiterated Rating	$122.00	$126.00	Equal Weight	$0.00 00.00% ROI
LEGN Legend Biotech	8/12/2025	Boost Price Target	$36.24	$83.00	Overweight	$0.00 00.00% ROI
IOBT IO Biotech	8/12/2025	Lower Price Target	$1.05	$4.00	Overweight	$0.00 00.00% ROI
VRTX Vertex Pharmaceuticals	8/5/2025	Set Price Target	$472.27	$439.00	Equal Weight	$0.00 00.00% ROI
REGN Regeneron Pharmaceuticals	8/1/2025	Reiterated Rating	$545.46	$761.00	Overweight	$0.00 00.00% ROI
MRNA Moderna	8/1/2025	Reiterated Rating	$29.56	$32.00	Equal Weight	$0.00 00.00% ROI
BIIB Biogen	8/1/2025	Lower Price Target	$124.95	$144.00	Equal Weight	$0.00 00.00% ROI
ARGX argenex	8/1/2025	Boost Price Target	$667.75	$766.00	Overweight	$0.00 00.00% ROI
SRPT Sarepta Therapeutics	7/29/2025	Boost Price Target	$13.86	$20.00	Equal Weight	$0.00 00.00% ROI
Get the Latest News and Ratings for Your Stocks Enter your email address below to receive the latest headlines and analysts' recommendations for your stocks with our free daily email newsletter.
BMRN BioMarin Pharmaceutical	7/22/2025	Lower Price Target	$58.00	$96.00	Overweight	$0.00 00.00% ROI
INSM Insmed	7/17/2025	Boost Price Target	$104.59	$108.00	Overweight	$0.00 00.00% ROI
R Ryder System	7/15/2025	Initiated Coverage	$175.19	$215.00	Positive	$0.00 00.00% ROI
LEGN Legend Biotech	7/10/2025	Reiterated Rating	$39.16	$81.00	Overweight	$0.00 00.00% ROI
REGN Regeneron Pharmaceuticals	7/10/2025	Lower Price Target	$561.21	$754.00	Overweight	$0.00 00.00% ROI
VRTX Vertex Pharmaceuticals	6/20/2025	Lower Price Target	$438.85	$460.00	Equal Weight	$0.00 00.00% ROI
SRPT Sarepta Therapeutics	6/16/2025	Reiterated Rating	$20.30	$40.00	Equal Weight	$0.00 00.00% ROI
INSM Insmed	6/11/2025	Boost Price Target	$94.94	$102.00	Overweight	$0.00 00.00% ROI
REGN Regeneron Pharmaceuticals	6/2/2025	Lower Price Target	$493.24	$755.00	Overweight	$0.00 00.00% ROI
SRPT Sarepta Therapeutics	5/7/2025	Lower Price Target	$46.75	$113.00	Overweight	$0.00 00.00% ROI
VRTX Vertex Pharmaceuticals	5/6/2025	Boost Price Target	$436.06	$464.00	Equal Weight	$0.00 00.00% ROI
GILD Gilead Sciences	4/25/2025	Boost Price Target	$103.65	$135.00	Overweight	$0.00 00.00% ROI
SRPT Sarepta Therapeutics	4/11/2025	Lower Price Target	$49.41	$182.00	Overweight	$0.00 00.00% ROI
AVIR Atea Pharmaceuticals	4/11/2025	Lower Price Target	$2.65	$6.00	Equal Weight	$0.00 00.00% ROI
BIIB Biogen	4/9/2025	Lower Price Target	$111.00	$152.00	Equal Weight	$0.00 00.00% ROI
MRNA Moderna	4/9/2025	Lower Price Target	$24.62	$32.00	Equal Weight	$0.00 00.00% ROI
LEGN Legend Biotech	3/17/2025	Lower Price Target	$38.25	$80.00	Overweight	$0.00 00.00% ROI
TSVT 2seventy bio	3/14/2025	Lower Price Target	$4.95	$5.00	Equal Weight	$0.00 00.00% ROI
TNYA Tenaya Therapeutics	3/12/2025	Lower Price Target	$0.54	$5.00	Overweight	$0.00 00.00% ROI
GILD Gilead Sciences	3/11/2025	Boost Price Target	$117.21	$130.00	Overweight	$0.00 00.00% ROI
DNLI Denali Therapeutics	3/7/2025	Initiated Coverage	$16.47	$33.00	Overweight	$0.00 00.00% ROI
BIIB Biogen	2/13/2025	Lower Price Target	$136.88	$157.00	Equal Weight	$0.00 00.00% ROI
GILD Gilead Sciences	2/12/2025	Boost Price Target	$96.14	$123.00	Overweight	$0.00 00.00% ROI
VRTX Vertex Pharmaceuticals	2/11/2025	Boost Price Target	$469.97	$459.00	Equal Weight	$0.00 00.00% ROI
INSM Insmed	2/6/2025	Boost Price Target	$81.44	$90.00	Overweight	$0.00 00.00% ROI
CMCSA Comcast	1/31/2025	Lower Price Target	$33.77	$55.00	Buy	$0.00 00.00% ROI
MRNA Moderna	1/15/2025	Lower Price Target	$35.00	$38.00	Equal Weight	$0.00 00.00% ROI

Stock Forecasts and Research Tools

Sign in to your free account to enjoy these benefits

• In-depth profiles and analysis for 20,000 public companies.
• Real-time analyst ratings, insider transactions, earnings data, and more.
• Our daily ratings and market update email newsletter.

Sign in to your free account to enjoy all that MarketBeat has to offer.

• Sign In
• Create Account

Your Email Address:

Email Address Required

Your Password:

Password Required

Log In

---

or

Sign in with Facebook Sign in with Google

Forgot your password?

Your Email Address:

Please enter your email address.

Please enter a valid email address

Choose a Password:

Please enter your password.

Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character.

Create My Account (Free)

---

or

Sign in with Facebook Sign in with Google

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.